His primary scientific interests are in Diabetes mellitus, Internal medicine, Endocrinology, Insulin and Type 1 diabetes. William V. Tamborlane interconnects Randomized controlled trial and Surgery in the investigation of issues within Diabetes mellitus. William V. Tamborlane has included themes like Glycated hemoglobin, Glucose meter and Confidence interval in his Randomized controlled trial study.
His Internal medicine research focuses on Obesity, Body mass index, Impaired glucose tolerance, Glucagon and Metabolism. The Insulin study combines topics in areas such as Adverse effect and Metabolic syndrome. His Type 1 diabetes research incorporates elements of Young adult, Diabetic ketoacidosis, Research design and Pediatrics.
William V. Tamborlane mainly focuses on Diabetes mellitus, Internal medicine, Type 1 diabetes, Endocrinology and Insulin. His studies in Diabetes mellitus integrate themes in fields like Randomized controlled trial and Pediatrics. His research links Type 2 diabetes with Internal medicine.
His Type 1 diabetes research focuses on Intensive care medicine and how it connects with Blood Glucose Self-Monitoring. Glucagon, Glucose clamp technique, Hyperinsulinemia, Epinephrine and Carbohydrate metabolism are among the areas of Endocrinology where the researcher is concentrating his efforts. His biological study spans a wide range of topics, including Artificial pancreas and Metabolism.
His primary areas of investigation include Diabetes mellitus, Type 1 diabetes, Internal medicine, Glycemic and Pediatrics. The various areas that William V. Tamborlane examines in his Diabetes mellitus study include Insulin, Cohort and Intensive care medicine. His research integrates issues of Diabetic ketoacidosis, Gerontology and Kidney disease in his study of Type 1 diabetes.
The concepts of his Internal medicine study are interwoven with issues in Endocrinology and Type 2 diabetes. His Glycemic study combines topics in areas such as Randomized controlled trial, Diabetes duration and Family medicine. The Pediatrics study combines topics in areas such as White matter and Surgery.
His primary areas of study are Diabetes mellitus, Type 1 diabetes, Glycemic, Internal medicine and Pediatrics. He combines topics linked to Insulin with his work on Diabetes mellitus. His research in Type 1 diabetes intersects with topics in Young adult, Diabetic ketoacidosis, Research design and Increased risk.
William V. Tamborlane combines subjects such as Randomized controlled trial, Diabetes duration and Renal function with his study of Glycemic. His Internal medicine study integrates concerns from other disciplines, such as Cross-sectional study and Endocrinology. His work is dedicated to discovering how Pediatrics, Surgery are connected with Cohort and other disciplines.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Obesity and the metabolic syndrome in children and adolescents.
Ram Weiss;James Dziura;Tania S. Burgert;William V. Tamborlane.
The New England Journal of Medicine (2004)
Prevalence of Impaired Glucose Tolerance among Children and Adolescents with Marked Obesity
Ranjana Sinha;Gene Fisch;Barbara Teague;William V Tamborlane.
The New England Journal of Medicine (2002)
Continuous glucose monitoring and intensive treatment of type 1 diabetes.
Tamborlane Wv;Beck Rw;Bode Bw.
The New England Journal of Medicine (2008)
Impaired insulin action in puberty. A contributing factor to poor glycemic control in adolescents with diabetes.
Stephanie A. Amiel;Robert S. Sherwin;Donald C. Simonson;Albert A. Lauritano.
The New England Journal of Medicine (1986)
Current State of Type 1 Diabetes Treatment in the U.S.: Updated Data From the T1D Exchange Clinic Registry
Kellee M. Miller;Nicole C. Foster;Roy W. Beck;Richard M. Bergenstal.
Diabetes Care (2015)
International Consensus on Use of Continuous Glucose Monitoring
Thomas Danne;Revital Nimri;Tadej Battelino;Richard M. Bergenstal.
Diabetes Care (2017)
Effectiveness of Sensor-Augmented Insulin-Pump Therapy in Type 1 Diabetes
Richard M. Bergenstal;William V. Tamborlane;Andrew Ahmann;John B. Buse.
The New England Journal of Medicine (2010)
State of Type 1 Diabetes Management and Outcomes from the T1D Exchange in 2016–2018
Nicole C Foster;Roy W Beck;Kellee M Miller;Mark A Clements.
Diabetes Technology & Therapeutics (2019)
Epidemiology of Diabetes Interventions and Complications (EDIC): Design, implementation, and preliminary results of a long-term follow-up of the Diabetes Control and Complications Trial cohort
H. Shamoon;P. Cleary;A. Barnie;S. Genuth.
Diabetes Care (1999)
Coping skills training for youth with diabetes mellitus has long-lasting effects on metabolic control and quality of life.
Margaret Grey;Elizabeth A. Boland;Maryanne Davidson;Ju Li.
The Journal of Pediatrics (2000)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
University of South Florida
Yale University
Yale University
Stanford University
Yale University
Tennessee Department of Health
Harvard Medical School
Yale University
Stanford University
HealthPartners
University of California, San Diego
Dalhousie University
University of Helsinki
Charles University
McMaster University
Hokkaido University
National University of Singapore
University of Wisconsin–Madison
University of Washington
Pompeu Fabra University
National Autonomous University of Mexico
Ben-Gurion University of the Negev
Autonomous University of Barcelona
Southeastern Louisiana University
Case Western Reserve University
United States Department of the Army